TrialAnnals of oncology : official journal of the European Society for Medical Oncology2012

Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial.

A J Zurita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.